Recordati Industria Chimica e Farmaceutica S.p.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 1,580.07 million compared to EUR 1,448.87 million a year ago. Net income was EUR 385.97 million compared to EUR 354.98 million a year ago.

Basic earnings per share from continuing operations was EUR 1.874 compared to EUR 1.725 a year ago. Diluted earnings per share from continuing operations was EUR 1.846 compared to EUR 1.698 a year ago.